Press Releases SanBio Company Limited

Equities

4592

JP3336750009

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
419 ^JPY	0.00%		-0.95%	-40.31%

Mar. 19	SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March	MT
Mar. 19	Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SanBio : Announcement on Granting Stock Options (Share Acquisition Rights)	22-08-16	PU
SanBio : Notice regarding appointment of new corporate officers	22-08-01	PU
SanBio : Update on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic Brain Injury (TBI) Program in Japan	22-07-22	PU
SanBio : Keizo Nakada to Join SanBio as Corporate Officer and Head of Production	22-07-01	PU
SanBio : Recording of Non-operating Income (Foreign Exchange Gains), Deferred Income Taxes, and Short-Term Loans Payable	22-06-15	PU
SanBio : Consolidated Financial Results for the Three Months Ended April 30, 2022	22-06-14	PU
SanBio : Andrew Liu to Join SanBio as Chief Strategy Officer	22-06-01	PU
SanBio : SB623 Demonstrated Sustained Improvement in Motor Impairment up to 48 Weeks and Associated with Improvement	22-04-05	PU
SB623 Demonstrated Sustained Improvement in Motor Impairment up to 48 Weeks and Associated with Improvement in Function and Activities of Daily Living in Patients with Chronic Traumatic Brain Injury	22-04-05	BU
SanBio : ［Delayed］Recording of Non-Operating Expenses (Financing Expenses)	22-03-23	PU
SanBio : Partial Amendment to the Articles of Incorporation, Reduction in Amounts of Stated Capital and Capital Reserves and Appropriation of Capital Surplus	22-03-11	PU
SanBio : Announcement on Issuance Plans of Stock Options (Share Acquisition Rights)	22-03-11	PU
SanBio : Consolidated Financial Results for the Fiscal Year Ended January 31, 2022	22-03-11	PU
SanBio : Presentation for Financial Results for the Fiscal Year Ending Jan.31, 2022	22-03-11	PU
SanBio: Notice Regarding Completion of Approval Filing for Japan SB623 Chronic TBI Program	22-03-07	BU
SanBio : Notice regarding completion of approval filing for Japan SB623 chronic TBI program	22-03-07	PU
SanBio : Consolidated Financial Results for the Nine Months Ended October 31, 2021	21-12-16	PU
SanBio : Notice on the recording of other comprehensive income, non-operating income, and non-operating expenses	21-12-15	PU
SanBio : Notice on Conclusion of Committed Credit Line Agreement with Resona Bank Ltd.	21-12-15	PU
SanBio Joins the Newly Formed National TBI Registry Coalition (NTRC) as a Founding Member Organization	21-12-15	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases SanBio Company Limited

Equities

4592

JP3336750009

Press Releases

Filters